Autism Biomarkers Consortium for Clinical Trails (ABC-CT) Study

What is the purpose of the ABC-CT study?

    • The purpose of this longitudinal study is to identify a set of sensitive and reliable measures that can be used in future clinical trials to objectively measure social impairment in individuals with autism spectrum disorders (ASD). Children will be assessed over a 6-month period using electroencephalography (EEG), eye tracking (ET) and other lab-based measures. The goal of this study is to accelerate the development of effective treatments for social impairment in ASD.

What is involved?

    • Children will be assessed at three time points over a 6-month period using clinician and caregiver assessments, electroencephalogram (EEG), eye-tracking (ET), and lab-based measures. A one-time blood sample will also be collected from ASD subjects and their biological parents.

Who Can Participate?

    • Children 6 to 11 years old
    • Children with an autism spectrum diagnosis
    • Children of typical development who do not have an ASD diagnosis or siblings with ASD

What will you receive if you participate?

    • Up to $300 in compensation
    • Parking Validation
    • Transporation to and from the study site if necessary
    • Two feedback reports with clinical and cognitive assessment results after the initial and final visit

Interested in participating?

Email our research team at with your name and phone number and one of our coordinators will give you a call.